Peltz’s Trian Builds Stake in 3M Health Spinoff Solventum (2)

Activist investor Nelson Peltz’s Trian Fund Managementhas amassed a stake in 3M Co.’s health-care spinoff Solventum Corp.

Trian is now one of the largest shareholders in Solventum, which became a standalone public company this year and has a market value of about $9.4 billion, a representative for Trian said in an emailed statement, confirming a report by Bloomberg News. The exact size of Trian’s holding couldn’t immediately be learned.

Nelson Peltz

Photographer: Marco Bello/Bloomberg

New York-based Trian has reached out to Solventum to discuss ways to unlock shareholder value. The activist investor believes the company should re-accelerate organic growth, restore margins ...